Delta(9)-tetrahydrocannabinol Enhances an Increase of Plasma Corticosterone Levels Induced by Forced Swim-Stress
Statistics The forced swim data and the group 2 of plasma corticosterone levels were analyzed using one-way analysis of variance (ANOVA) followed by the TukeyKramer post-hoc test. The group 1 of plasma corticosterone levels were analyzed using the Student's t-test. The criterion for statistical significance was considered to be pϽ0. 05 Fig. 1b) . THC had no effect on plasma corticosterone levels before exposure to forced swim-stress on day 2 (vehicle: 347.7Ϯ62.7 ng/ml, THC 6 mg/kg: 398.2Ϯ44.2 ng/ml, Fig. 2 ). However, THC (6 mg/kg), together with forced swim-stress on day 2, significantly increased plasma corticosterone levels. This effect was inhibited by O-2050 (10 mg/kg) (vehicle: 327.4Ϯ28.0 ng/ml, THC 6 mg/kg: 684.1Ϯ87.2 ng/ml, THC 6 mg/kg-O2050 10 mg/kg: 374.7Ϯ12.5 ng/ml, F 2, 12 ϭ13.2, pϽ0.01, Fig. 2 ). DISCUSSION THC (2, 6 mg/kg) significantly prolonged the immobility time of mice during the forced swim test, a test with a high predictability of antidepressant efficacy in human depression.
12) O-2050 (10 mg/kg) was also able to reverse the enhancement of immobility by THC. These results indicate that this enhancement effect is mediated by cannabinoid CB 1 receptor. We previously reported that THC at a dose of 6 mg/kg did not significantly affect locomotor activity, motor coordination in rota-rod test and catalepsy-like immobilization. 13, 14) Therefore, the THC-induced enhancement of immobility is unlikely to have been caused by deficits in motor function.
Recently, it has been reported that depression is implicated in hyperactivity of the HPA-axis. Indeed, elevated plasma cortisol levels are exhibited in depressive disorder.
2) Moreover, corticosterone exposure elicits depressive-like behavior. 15 ) Therefore, we investigated the effects of THC on plasma corticosterone levels. Basal corticosterone levels were 118.4Ϯ35.1 ng/ml in intact male mice, which were 366.9Ϯ37.7 ng/ml after forced swim-stress for 15 min on day 1 (data not shown). THC had no effect on plasma corticosterone levels under non-stress conditions on day 2. However, THC together with forced swim-stress significantly increased plasma corticosterone levels. This increase of corticosterone concentration was antagonized by O-2050, suggesting that THC, via the CB 1 receptor, potentiates sensitivity of the HPA-axis to stress, which is involved in depressive-like behavior during the forced swim-stress. It has been reported that unpredictable stress and glucocorticoid treatment decreases expression of the CB 1 receptor in the hippocampus. 16, 17) The effect of glucocorticoids on CB 1 receptor expression is be mediated by the ability of glucocorticoids to negatively regulate transcription of the CB 1 receptor. 18) Therefore, it is suggested that an abnormality of glucocorticoid system by the forced swim-stress induces alteration of the endocannabinoid system, and the administration of THC in the condition enhances the responses to CB 1 receptors. This idea is supported by several studies demonstrating that adrenalectomy or pharmacological disruption of glucocorticoid receptor activity result in a potentiation of the responses to cannabinoid-related drug administration. [19] [20] [21] induces anxiolytic effect via GABAergic mechanisms in mice and anxiogenic effect via glutamatergic mechanisms in rats. 23) Thus, this discrepancy might depend on species difference in the effects of THC on an activation of the HPAaxis.
It has been reported that WIN 55,212-2 is not able to modify basal adrenocorticotropic hormone (ACTH) levels, but simultaneous application of corticotropin-releasing hormone (CRH) and WIN results in a synergistic effect on ACTH secretion from the human pituitary gland, and this effect is abolished by the CB 1 antagonist SR141716. 24) Furthermore, CRH mRNA in the paraventricular nucleus of the hypothalamus is increased by restraint stress. 25) Taken together with these observations, the present results suggest that THC might act to enhance the susceptibility of the HPA-axis to stress via a synergistic action with stress-induced elevated CRH levels. However, the functional significance of CB 1 receptor in the HPA-axis remains to be elucidated. Further experiments will be needed to clarify the possible role of the cannabinoid system in the modulation of the HPA-axis.
In conclusion, the study presented here demonstrates for the first time that THC, acting synergistically with stress, increases plasma corticosterone levels. These findings suggest that, in cannabis users, the susceptibility of the HPA-axis to stress is enhanced in stressful situations, thereby increasing the risk of depression.
